# A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma

> **NCT01244984** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 243 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fluticasone Furoate/GW642444 Inhalation Powder
- **DRUG:** Fluticasone Furoate Inhalation Powder

## Key facts

- **NCT ID:** NCT01244984
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 243 (ACTUAL)
- **Last updated:** 2017-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01244984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01244984, "A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01244984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*